Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Luley

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Clinical Chemistry|May 1, 1995
Direct determination of lipoprotein(a) cholesterol by ultracentrifugation and agarose gel electrophoresis with enzymatic staining for cholesterolM Nauck, K Winkler, C Wittmann, et al.
Clinical Nephrology|March 9, 1999
Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal diseaseJ Dierkes, U Domröse, A Ambrosch, et al.
British Journal of Cancer|October 1, 1989
Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C)C D Gerharz, H E Gabbert, R Engers, et al.
Clinical Chemistry and Laboratory Medicine|September 24, 1998
The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery diseaseJ Dierkes, E Bissé, M Nauck, et al.
Biochimica Et Biophysica Acta|November 5, 1991
Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratiosE von Hodenberg, S Heinen, K E Howell, et al.
Arzneimittel-Forschung|January 1, 1992
Fish oil treatment and apolipoprotein(a)C Luley, I Lelieur, M Hanisch, et al.
Kidney International|August 5, 1998
Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRDA Ambrosch, U Domroese, S Westphal, et al.
Clinical Nephrology|March 14, 2009
Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trialJ Heinz, U Domröse, C Luley, et al.
Diabetes Care|December 5, 1998
LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjectsA Ambrosch, I Mühlen, D Kopf, et al.
Circulation|October 18, 2000
Cardiac troponin T predicts mortality in patients with end-stage renal diseaseJ Dierkes, U Domröse, S Westphal, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|May 1, 1995
Direct determination of lipoprotein(a) cholesterol by ultracentrifugation and agarose gel electrophoresis with enzymatic staining for cholesterolM Nauck, K Winkler, C Wittmann, et al.
Clinical Nephrology|March 9, 1999
Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal diseaseJ Dierkes, U Domröse, A Ambrosch, et al.
British Journal of Cancer|October 1, 1989
Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C)C D Gerharz, H E Gabbert, R Engers, et al.
Clinical Chemistry and Laboratory Medicine|September 24, 1998
The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery diseaseJ Dierkes, E Bissé, M Nauck, et al.
Biochimica Et Biophysica Acta|November 5, 1991
Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratiosE von Hodenberg, S Heinen, K E Howell, et al.
Arzneimittel-Forschung|January 1, 1992
Fish oil treatment and apolipoprotein(a)C Luley, I Lelieur, M Hanisch, et al.
Kidney International|August 5, 1998
Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRDA Ambrosch, U Domroese, S Westphal, et al.
Clinical Nephrology|March 14, 2009
Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trialJ Heinz, U Domröse, C Luley, et al.
Diabetes Care|December 5, 1998
LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjectsA Ambrosch, I Mühlen, D Kopf, et al.
Circulation|October 18, 2000
Cardiac troponin T predicts mortality in patients with end-stage renal diseaseJ Dierkes, U Domröse, S Westphal, et al.
Pageof 9